← Back to Search

CGM Implementation for Diabetes (PREPARE4CGM Trial)

N/A
Waitlist Available
Led By Tamara Oser, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Has diagnosis of type 1 diabetes or type 2 diabetes
Between ages of 18 and 89 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3, 6, and 12 months from baseline
Awards & highlights

PREPARE4CGM Trial Summary

This trial will help to understand how to best implement and use continuous glucose monitors in primary care practices so that more patients have access to this technology.

Who is the study for?
This trial is for adults aged 18-89 with type 1 or type 2 diabetes, who are recommended by their primary care doctor to use continuous glucose monitoring (CGM). Participants must be able to read or speak English or Spanish. Pregnant women and those outside the age range cannot join.Check my eligibility
What is being tested?
The study tests three ways of implementing CGM in primary care: an educational module only, the module plus practice facilitation support, and a virtual CGM initiation clinic. Up to 500 patients across up to 90 practices will compare these methods over three years.See study design
What are the potential side effects?
Since this trial focuses on implementation strategies rather than medication, traditional side effects are not a concern. However, participants may experience discomfort from wearing the CGM device.

PREPARE4CGM Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with diabetes.
Select...
I am between 18 and 89 years old.

PREPARE4CGM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3, 6, and 12 months from baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3, 6, and 12 months from baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in practice-reported prescriptions of Continuous Glucose Monitors
Secondary outcome measures
Cost Analysis and Economic Sustainability
Diabetes-related distress
Glucose
+6 more

PREPARE4CGM Trial Design

3Treatment groups
Experimental Treatment
Group I: ReferExperimental Treatment1 Intervention
Practice referral of patients to a virtual CGM initiation service
Group II: Learn + Practice FacilitationExperimental Treatment2 Interventions
Practice completion of online educational module, American Academy of Family Physicians (AAFP) Transformation in Practice Series (TIPS) on continuous glucose monitoring in primary care plus practice facilitation
Group III: LearnExperimental Treatment1 Intervention
Practice completion of online educational module, American Academy of Family Physicians (AAFP) Transformation in Practice Series (TIPS) on continuous glucose monitoring in primary care

Find a Location

Who is running the clinical trial?

The Leona M. and Harry B. Helmsley Charitable TrustOTHER
57 Previous Clinical Trials
93,728 Total Patients Enrolled
University of Colorado, DenverLead Sponsor
1,732 Previous Clinical Trials
2,143,358 Total Patients Enrolled
Tamara Oser, MDPrincipal InvestigatorUniversity of Colorado Denver | Anschutz Medical Campus
2 Previous Clinical Trials
236 Total Patients Enrolled

Media Library

Type 2 Diabetes Research Study Groups: Refer, Learn, Learn + Practice Facilitation
Type 2 Diabetes Clinical Trial 2023: Online educational module on CGM Highlights & Side Effects. Trial Name: NCT05336214 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies left on this research project?

"The data hosted on clinicaltrials.gov states that this trial is currently not recruiting participants; the study was opened on June 7th 2022 and updated lastly on June 13th of the same year. Although no new enrollees are being accepted at present, there exist 1478 other trials seeking patients across various locations."

Answered by AI

Is it feasible for me to join this research program?

"This medical trial seeks 500 participants suffering from diabetes and autoimmune diseases, aged between 18 to 89. Candidates who meet these criteria are eligible for the study."

Answered by AI

Is this experiment available to participants aged 55 and over?

"This clinical trial is open to participants aged 18-89. There are 224 studies for those under the age of majority and 1,115 trials that focus on individuals over retirement age."

Answered by AI
~67 spots leftby Apr 2025